Price to Sales (P/S)
since 2005
Calculation
Merck & Co. Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Sales1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | 5.43 | = | 128.84 | ÷ | 23.74 | 23.74 | = | 60,115 | ÷ | 2,532,643,872 | |
| Feb 24, 2023 | 4.71 | = | 109.89 | ÷ | 23.35 | 23.35 | = | 59,283 | ÷ | 2,538,592,467 | |
| Feb 25, 2022 | 3.96 | = | 76.32 | ÷ | 19.27 | 19.27 | = | 48,704 | ÷ | 2,527,733,606 | |
| Feb 25, 2021 | 3.93 | = | 74.62 | ÷ | 18.97 | 18.97 | = | 47,994 | ÷ | 2,530,315,668 | |
| Feb 26, 2020 | 4.33 | = | 79.94 | ÷ | 18.47 | 18.47 | = | 46,840 | ÷ | 2,536,268,760 | |
| Feb 27, 2019 | 4.92 | = | 80.62 | ÷ | 16.39 | 16.39 | = | 42,294 | ÷ | 2,581,220,308 | |
| Feb 27, 2018 | 3.68 | = | 54.72 | ÷ | 14.88 | 14.88 | = | 40,122 | ÷ | 2,696,190,502 | |
| Feb 28, 2017 | 4.54 | = | 65.87 | ÷ | 14.50 | 14.50 | = | 39,807 | ÷ | 2,745,571,067 | |
| Feb 26, 2016 | 3.56 | = | 50.64 | ÷ | 14.23 | 14.23 | = | 39,498 | ÷ | 2,775,258,591 | |
| Feb 27, 2015 | 3.93 | = | 58.54 | ÷ | 14.88 | 14.88 | = | 42,237 | ÷ | 2,838,192,933 | |
| Feb 27, 2014 | 3.78 | = | 56.66 | ÷ | 14.97 | 14.97 | = | 44,033 | ÷ | 2,940,622,461 | |
| Feb 28, 2013 | 2.73 | = | 42.73 | ÷ | 15.64 | 15.64 | = | 47,267 | ÷ | 3,022,367,538 | |
| Feb 28, 2012 | 2.43 | = | 38.38 | ÷ | 15.78 | 15.78 | = | 48,047 | ÷ | 3,044,008,396 | |
| Feb 28, 2011 | 2.18 | = | 32.57 | ÷ | 14.92 | 14.92 | = | 45,987 | ÷ | 3,083,080,697 | |
| Mar 1, 2010 | 4.23 | = | 37.27 | ÷ | 8.80 | 8.80 | = | 27,428 | ÷ | 3,115,317,260 | |
| Feb 27, 2009 | 2.14 | = | 24.20 | ÷ | 11.32 | 11.32 | = | 23,850 | ÷ | 2,107,712,364 | |
| Feb 28, 2008 | 4.04 | = | 45.20 | ÷ | 11.18 | 11.18 | = | 24,198 | ÷ | 2,165,289,746 | |
| Feb 28, 2007 | 4.23 | = | 44.15 | ÷ | 10.45 | 10.45 | = | 22,636 | ÷ | 2,166,483,163 | |
| Mar 13, 2006 | 3.50 | = | 35.20 | ÷ | 10.06 | 10.06 | = | 22,012 | ÷ | 2,187,042,320 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Merck & Co. Inc. Annual Report.
Comparison to Competitors
Merck & Co. Inc., P/S, long-term trends, comparison to competitors
| Merck & Co. Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | 5.43 | 5.72 | 5.78 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 2.66 | 7.84 | 4.99 | 11.16 |
| Feb 24, 2023 | 4.71 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 2.37 | 7.01 | 4.73 | 8.56 |
| Feb 25, 2022 | 3.96 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.18 | 4.20 | 5.39 | 8.21 |
| Feb 25, 2021 | 3.93 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 4.50 | 6.24 | 5.52 | 8.82 |
| Feb 26, 2020 | 4.33 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 3.66 | 5.34 | 4.83 | 14.95 |
| Feb 27, 2019 | 4.92 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.49 | 6.62 | 4.24 | 15.54 |
| Feb 27, 2018 | 3.68 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 4.05 | 5.92 | 4.01 | 16.42 |
| Feb 28, 2017 | 4.54 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 3.84 | 7.86 | 3.37 | 12.51 |
| Feb 26, 2016 | 3.56 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.76 | 9.38 | 3.05 | 20.38 |
| Feb 27, 2015 | 3.93 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 4.24 | 14.62 | 3.06 | 47.41 |
| Feb 27, 2014 | 3.78 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.97 | 15.52 | 3.74 | 16.53 |
| Feb 28, 2013 | 2.73 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 3.34 | 11.66 | 2.12 | 6.60 |
| Feb 28, 2012 | 2.43 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.37 | 20.90 | 1.77 | 5.61 |
| Feb 28, 2011 | 2.18 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.27 | 7.38 | 2.00 | 56.82 |
| Mar 1, 2010 | 4.23 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 2.83 | 5.74 | 1.98 | 80.12 |
| Feb 27, 2009 | 2.14 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 1.72 | 5.17 | 1.44 | 28.70 |
| Feb 28, 2008 | 4.04 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 3.11 | 11.94 | 2.40 | 12.17 |
| Feb 28, 2007 | 4.23 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 3.67 | 19.70 | 5.05 | 17.58 |
| Mar 13, 2006 | 3.50 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.77 | 14.06 | 2.15 | 26.93 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Merck & Co. Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Merck & Co. Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 26, 2024 | 5.43 | 5.90 |
| Feb 24, 2023 | 4.71 | 4.57 |
| Feb 25, 2022 | 3.96 | 4.51 |
| Feb 25, 2021 | 3.93 | 4.91 |
| Feb 26, 2020 | 4.33 | 4.88 |
| Feb 27, 2019 | 4.92 | 4.54 |
| Feb 27, 2018 | 3.68 | 4.60 |
| Feb 28, 2017 | 4.54 | 4.29 |
| Feb 26, 2016 | 3.56 | 4.10 |
| Feb 27, 2015 | 3.93 | 4.54 |
| Feb 27, 2014 | 3.78 | 4.30 |
| Feb 28, 2013 | 2.73 | 3.25 |
| Feb 28, 2012 | 2.43 | 2.58 |
| Feb 28, 2011 | 2.18 | 2.44 |
| Mar 1, 2010 | 4.23 | 3.00 |
| Feb 27, 2009 | 2.14 | 2.22 |
| Feb 28, 2008 | 4.04 | 3.19 |
| Feb 28, 2007 | 4.23 | 3.88 |
| Mar 13, 2006 | 3.50 | 3.84 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Merck & Co. Inc., P/S, long-term trends, comparison to industry (health care)
| Merck & Co. Inc. | Health Care | |
|---|---|---|
| Feb 26, 2024 | 5.43 | 2.46 |
| Feb 24, 2023 | 4.71 | 35,311.43 |
| Feb 25, 2022 | 3.96 | 2.39 |
| Feb 25, 2021 | 3.93 | 2.33 |
| Feb 26, 2020 | 4.33 | 2.24 |
| Feb 27, 2019 | 4.92 | 2.45 |
| Feb 27, 2018 | 3.68 | 2.43 |
| Feb 28, 2017 | 4.54 | 2.24 |
| Feb 26, 2016 | 3.56 | 2.23 |
| Feb 27, 2015 | 3.93 | 2.54 |
| Feb 27, 2014 | 3.78 | 2.31 |
| Feb 28, 2013 | 2.73 | 1.82 |
| Feb 28, 2012 | 2.43 | 1.63 |
| Feb 28, 2011 | 2.18 | 1.54 |
| Mar 1, 2010 | 4.23 | 1.73 |
| Feb 27, 2009 | 2.14 | 1.43 |
| Feb 28, 2008 | 4.04 | 2.09 |
| Feb 28, 2007 | 4.23 | 2.53 |
| Mar 13, 2006 | 3.50 | 2.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).